SELLAS Life Sciences Group, Inc. Common Stock
SLS
$9.04
+10.38%
SLS
SELLAS Life Sciences Group, Inc. Common Stock
$9.04
SLS price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on SELLAS Life Sciences Group, Inc. Common Stock's 12-month outlook, with a consensus price target around $11.75 and implied upside of +30.0% versus the current price.
Average Target
$11.75
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$7 - $12
Analyst target range
SLS Technical Analysis
Beta
2.24
2.24x market volatility
Max Drawdown
-36.5%
Largest decline past year
52-Week Range
$1-$10
Price range past year
Annual Return
+465.0%
Cumulative gain past year
| Period | SLS Return | S&P 500 |
|---|---|---|
| 1m | +85.6% | +4.6% |
| 3m | +63.5% | +12.6% |
| 6m | +419.5% | +10.4% |
| 1y | +465.0% | +27.0% |
| ytd | +107.8% | +11.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is SLS Overvalued?
PE
-15.3x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-12.0x
Enterprise Value Multiple